Hepatitis C virus--a pathogen for all people.
作者信息
Dove L, Wright T L
出版信息
West J Med. 1996 Jun;164(6):532-3.
Abstract
摘要
相似文献
1
Hepatitis C virus--a pathogen for all people.丙型肝炎病毒——一种危害所有人的病原体。
West J Med. 1996 Jun;164(6):532-3.
2
Scope of worldwide hepatitis C problem.全球丙型肝炎问题的范围。
Liver Transpl. 2003 Nov;9(11):S10-3. doi: 10.1053/jlts.2003.50244.
3
The hepatitis C crisis.丙型肝炎危机。
Ethn Dis. 2005 Spring;15(2 Suppl 2):S52-7.
4
Emerging epidemic. Decades after hiding out in millions of bodies, the hepatitis C virus is ready to rock and kill.新出现的流行病。在隐匿于数百万人的身体数十年后，丙型肝炎病毒准备肆虐并夺命了。
US News World Rep. 2006 Mar 13;140(9):60-2.
5
HCV: the Indian scenario.丙型肝炎病毒：印度的情况。
Trop Gastroenterol. 2006 Jul-Sep;27(3):105-10.
6
Occult hepatits C virus persistence: identification and characteristics.
MLO Med Lab Obs. 2006 Feb;38(2):20-2.
7
Noninjection drug use: an under-appreciated risk factor for hepatitis C virus transmission.非注射吸毒：丙型肝炎病毒传播的一个未得到充分重视的风险因素。
Liver Int. 2008 Jul;28(6):757-60. doi: 10.1111/j.1478-3231.2008.01765.x.
8
Hepatitis C virus infection--its role in pathogenesis.丙型肝炎病毒感染——其在发病机制中的作用。
J Infect Dis. 2007 Jan 15;195(2):168-70. doi: 10.1086/510250. Epub 2006 Dec 11.
9
Summary report and recommendations of the Expert Working Groups for Strain and Laboratory Surveillance of Hepatitis B Virus and Hepatitis C Virus.乙型肝炎病毒和丙型肝炎病毒毒株及实验室监测专家工作组总结报告与建议
Can Commun Dis Rep. 1999 Oct 15;25(20):169-73.
10
Outcome of screening for hepatitis C virus infection based on risk factors.基于风险因素的丙型肝炎病毒感染筛查结果
Am J Gastroenterol. 2008 Jan;103(1):131-7. doi: 10.1111/j.1572-0241.2007.01522.x. Epub 2007 Sep 25.
本文引用的文献
1
Clinical sequelae of hepatitis C acquired from injection drug use.注射吸毒感染丙型肝炎的临床后遗症。
West J Med. 1996 May;164(5):399-404.
2
The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses.慢性丙型肝炎的自然病程：1型和2型丙型肝炎病毒感染患者的比较。
Hepatology. 1996 Apr;23(4):695-9. doi: 10.1053/jhep.1996.v23.pm0008666319.
3
The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.
Hepatology. 1993 Dec;18(6):1338-43.
4
Interferon and hepatitis C.
N Engl J Med. 1995 Jun 1;332(22):1509-11. doi: 10.1056/NEJM199506013322211.
5
Clinical outcomes after transfusion-associated hepatitis C.输血相关性丙型肝炎后的临床结局
N Engl J Med. 1995 Jun 1;332(22):1463-6. doi: 10.1056/NEJM199506013322202.
6
Chronic non-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically. Outcome during long-term follow-up--a comparison.慢性非甲非乙型肝炎可在输血、非法自我注射后发生，或呈散发性。长期随访结果——一项比较。
Liver. 1989 Apr;9(2):120-7. doi: 10.1111/j.1600-0676.1989.tb00388.x.
7
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.
Hepatology. 1990 Oct;12(4 Pt 1):671-5. doi: 10.1002/hep.1840120409.
8
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.输血相关的非甲非乙型肝炎后的长期死亡率。国家心肺血液研究所研究小组。
N Engl J Med. 1992 Dec 31;327(27):1906-11. doi: 10.1056/NEJM199212313272703.
9
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.美国社区获得性丙型肝炎的自然史。哨兵县慢性非甲非乙型肝炎研究小组。
N Engl J Med. 1992 Dec 31;327(27):1899-905. doi: 10.1056/NEJM199212313272702.
Zotero 插件